Common numbing drug tested as potential weapon against aggressive breast cancer
NCT ID NCT07458204
Summary
This study is testing whether injecting a common local anesthetic (levobupivacaine) around the tumor and nearby nerves before breast-conserving surgery can help patients with triple-negative breast cancer. The goal is to see if this simple addition to standard surgery can reduce the risk of the cancer coming back or spreading, thereby improving survival. The trial will involve 760 women who have already had chemotherapy and are scheduled for surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Godinot
Reims, Champagne-Ardenne, 51100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.